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INTRODUCTION
Over the past several years, the 
combination of functional genomics, 
proteomics, and bioinformatics has 
contributed significantly to the identi-
fication of novel molecules that now 
serve as valid targets for therapeutic 
intervention against various diseases. 
Rapid generation of lead compounds 
that will inhibit or, in some cases, 
potentiate the activities of these target 
molecules necessitates the availability 
of robust, sensitive, and cost-effective 
assays. Previously, biochemical assays 
were used more than cell-based assays, 
but, due to emerging technologies, 
this trend is changing, and the demand 
for cell-based assays is gradually 
increasing. Although biochemical 
assays are well-defined, sensitive, and 
easy to miniaturize, they are nonphysi-
ological and require purified protein. 
Moreover, biochemical assays can be 
challenging to develop for difficult-to-
purify (but nonetheless therapeutically 
important) proteins, such as membrane 
receptors, ion channels, and G protein-
coupled receptors (GPCRs). In contrast, 
cell-based assays offer investigators the 
luxury of probing biological activity 
of a protein or a pathway in its natural 
physiological milieu, and therefore are 
closer to recapitulating the actual in 
vivo situation.
CURRENT REPORTER GENE 
DETECTION SYSTEMS
The success of cell-based assays 
depends entirely on the quality of 
the reporter gene. To date, numerous 
reporter genes have been used for 
monitoring gene expression (1). While 
useful, most commercially available 
reporter technologies are not versatile 
enough to cover every aspect of cell-
based assay development and screening 
(see Table 1). For instance, although 
luciferase-based assays provide 
acceptable sensitivity and an excellent 
dynamic range, they cannot be used 
for fluorescence-activated cell sorting 
(FACS), because the bioluminescent 
emission produced after the breakdown 
of D-luciferin is only transient. Thus, 
deriving stable cell lines from single 
cells expressing luciferase necessi-
tates labor-intensive serial dilutions 
and makes this system ill-suited for 
cell-based assay development (1). 
Secreted alkaline phosphatase (seAP) 
is another reporter system in which 
the expressed seAP is detected when it 
activates a dioxetane derivative, which 
decomposes and emits light during the 
decomposition process. Like luciferase, 
the seAP system is incompatible with 
FACS, and developing seAP expressing 
cell lines from single cells also requires 
time-consuming and labor-intensive 
serial dilutions. The oldest reporter 
system, chloramphenicol acetyl trans-
ferase (CAT), requires a radioactive 
substrate; this feature reduces its utility 
for many researchers.
Another usable reporter gene is the 
lacZ encoded enzyme β-galactosidase 
(1). Historically, this reporter gene has 
served as a valuable tool for cell and 
developmental biologists. The activity 
of β-galactosidase, comprised of a 
homotetramer of 116-kDa subunits, in 
a cell or fixed tissue can be monitored 
colorimetrically with its substrate 5-
bromo-4-chloro-3-indolyl-β-d-galac-
topyranoside (X-gal), which produces 
a blue precipitate upon cleavage. This 
enzyme’s activity may also be detected 
fluorometrically in live cells with 
the synthetic substrate, fluorescein-
β-digalactopyranoside (FDG) (2). 
Whereas the native substrate does not 
fluoresce, β-galactosidase cleavage 
of FDG produces free fluorescein 
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that can be detected in live cells by 
epifluorescence microscopy or flow 
cytometry. Although the β-galacto-
sidase/FDG combination has been 
used in FACS, it has shortcomings (3). 
First, because FDG is polar, it does not 
readily cross the plasma membrane. 
To introduce FDG inside cells, they 
must be subjected to a harsh hypotonic 
shock procedure, which leads to 
uneven substrate loading. Since 
fluorescence signal intensity from the 
cells depends on both enzyme and 
substrate concentrations, it is affected 
by uneven substrate loading. Second, 
the free fluorescein produced by FDG 
cleavage rapidly diffuses out of the 
cell. To minimize this efflux, cells 
must be kept on ice during the entire 
loading period. Currently, no other 
commercially available lipophilic 
substrate exists that can readily cross 
the cell membrane and quantitatively 
report the expression levels of β-galac-
tosidase within a cell. In spite of the 
problems associated with the β-galac-
tosidase/FDG system, it has been used 
as a tool for studying protein-protein 
interactions in live cells (4).
Green fluorescent protein (GFP) 
from the jellyfish Aequorea victoria 
is another commonly used reporter 
system (5). The main advantage of GFP 
is that it is noninvasive and inherently 
fluorescent (i.e., it requires no substrate 
for detection). In addition, using 
different spectrally resolved mutants of 
GFP enables an investigator to track the 
expression of two (or more) genes in 
the same cell (multiplexing). As a non-
enzymatic reporter, however, GFP’s 
limit of detection is approximately 105 
molecules/cell. The low sensitivity of 
GFP undermines its effectiveness as a 
good reporter system.
β-LACTAMASE: A REPORTER 
FOR ALL SEASONS
The β-lactamase reporter system 
makes use of the enzyme TEM-1 
β-lactamase (BLA), which lacks the 
N-terminal 23 amino acid periplasmic 
secretory signal sequence. BLA is a 29-
kDa enzyme encoded by the ampicillin 
resistance gene (ampr) that is active 
either as a monomer or when fused N or 
C terminally to a heterologous protein 
(6) and can cleave β-lactam-containing 
molecules like penicillins and cephalo-
sporins with simple kinetics and high 
catalytic efficiency. No ortholog of 
Figure 1. Illustration of the β-lactamase reporter system. After an esterified (acetoxymethylated; AM) form of this substrate CCF2/4 (CCF2/4-AM) enters 
a cell, endogenous esterases convert it to CCF2/4, thereby trapping it inside the cell. Exciting CCF2/4 at 408 nm leads to efficient FRET from the coumarin 
moiety to the fluorescein derivative and produces green fluorescence detectable at 530 nm. After β-lactamase cleaves CCF2/4, the two fluorophores separate, 
causing loss of fluorescence resonance energy transfer (FRET); excitation at 408 nm now results in blue fluorescence detectable at 460 nm.
����������
Table 1. Characteristics of Gene Reporter Systems 
Reporter Gene Enzyme Amplification Miniaturizable Ratiometric FACS-Compatible Stable Cell Lines
β-Lactamase +++ +++ +++ +++ +++
Luciferase +++ ++ — — +
Secreted AP +++ + — — +
CAT +++ — — — —
β-Galactosidase +++ ++ — ++ ++
GFP — + — +++ +++
FACS, fluorescence-activated cell sorting; AP, alkaline phosphatase; CAT, chloramphenicol acetyl transferase; GFP, green fluorescent protein; +++, highly 
appropriate; ++, appropriate; +, time-consuming or labor-intensive; —, inappropriate.
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BLA exists in eukaryotes. Additionally, 
overexpression of BLA is not accom-
panied by any apparent toxicity in 
eukaryotic cells.
The effectiveness of BLA as a 
reporter gene was not realized until 
Zlokarnik and colleagues reported 
the synthesis of a fluorogenic BLA 
substrate CCF2 (7). Another BLA 
substrate, CCF4, is relatively more 
soluble than CCF2 in aqueous solutions 
and is therefore preferred over CCF2 for 
some applications. CCF2/4 is composed 
of two fluorescent dyes, 7-hydroxycou-
marin-3-carboxamide and fluorescein, 
bridged by cephalosporin. The esterified 
(acetoxymethylated; AM) form of this 
substrate, CCF2/4-AM, is lipophilic 
and readily traverses cell membranes 
without stressing or damaging live 
cells. As shown in Figure 1, once 
CCF2/4-AM enters a cell, endogenous 
esterases convert it to CCF2/4. Because 
CCF2/4 is negatively charged at physi-
ological pH, it becomes trapped inside 
the cell. CCF2/4 can be easily detected 
by fluorescence resonance energy 
transfer (FRET). In the intact molecule, 
excitation of coumarin at 408 nm leads 
to efficient FRET (quantum yield 0.74) 
to the fluorescein derivative 
and produces green fluores-
cence (λ = 530 nm) (Figure 
2A). Cleavage of CCF2/4 by β-
lactamase, however, separates 
the two fluorophores, causing 
loss of FRET; excitation of 
coumarin now results in blue 
fluorescence (λ = 460 nm) 
(Figure 2B). Thus, based on 
the change in the color of 
the fluorescence emission 
signal, live cells expressing 
BLA can be unequivocally, 
simply, and rapidly (in as little 
as 1 h) distinguished from 
those that lack the enzyme by 
epifluorescence microscopy, 
fluorescent plate reader, or 
flow cytometry.
In the BLA-CCF2/4 
system, the green fluores-
cence observed immediately 
after delivering (loading) 
the substrate indicates that 
the intact substrate has 
been successfully loaded in 
each cell. This unique and 
powerful feature distinguishes 
BLA from other reporter systems, 
in which registering delivery of the 
substrate is impossible (e.g., loading 
the β-galactosidase substrate FDG 
into cells). Equally important, the 
CCF2/4 substrate enables ratiometric 
data analysis (the ratio of the net blue 
fluorescence signal intensity and the 
net green fluorescence signal intensity; 
em. 460/em. 530), which eliminates 
problems arising from well-to-well 
variations in cell number and fluores-
cence signal intensity.
Because neither BLA nor its 
substrate (intact or cleaved) is toxic, 
this reporter system can be used to not 
only monitor gene expression in live 
animals (8), but is also amenable for 
FACS, which can process as many as 
104 cells/s (9). Consequently, the BLA 
reporter system facilitates rapid devel-
opment of stably transfected clonal 
cell lines. With the CCF2/4 substrate, 
as few as 50 molecules BLA can be 
detected within a cell (7). This combi-
nation of enzymatic fluorescence signal 
amplification and ratiometric data 
analysis produces exquisitely sensitive 
and specific BLA-based assays that are 
ideally suited for ultraminiaturizable 
high-throughput screening (HTS) 
applications (10).
Besides being useful as a traditional 
reporter that allows easy monitoring 
of signaling pathways in live cells (6), 
BLA-based cell-based assays have 
been developed for various classes of 
gene families including GPCRs and 
nuclear hormone receptors (11–15). 
This biosensor has also been used for 
studying protein folding (16), adaptive 
and targeted gene evolution (17,18), 
protease activity (19), gene trapping 
(20,21), fusion of human immunodefi-
ciency virus (HIV) virions to primary 
CD4+ T lymphocytes (22,23), RNA 
splicing (24), and protein-protein 
interactions by fragment complemen-
tation (25–28). In one report, the BLA 
reporter system was used for identi-
fying inhibitors of hepatitis C viral 
replication (29).
In spite of its many attractive features, 
some of the shortcomings associated 
with the BLA-CCF2/4 system are 
that it has poor dynamic range and its 
substrate CCF2/4 has a high molecular 
weight and poor solubility in aqueous 
solutions. In light of this, there is a 
need for superior new-generation BLA 
substrates, such as CC1 (30), that will 
further improve the quality and effec-
tiveness of this reporter.
DEVELOPING A 
GLUCOCORTICOID RECEPTOR 
CELL-BASED ASSAY WITH 
β-LACTAMASE USING 
ONE-ARM HOMOLOGOUS 
RECOMBINATION
A member of the nuclear receptor 
superfamily, the glucocorticoid receptor 
(GR) is a ligand-activated transcrip-
tional regulator. GR mediates glucocor-
ticoid action that controls carbohydrate, 
protein, and fat metabolism, suppresses 
the immune/inflammatory responses, 
regulates cardiovascular function, 
and affects basal and stress-related 
homeostasis. Glucocorticoid therapies 
are used to treat asthma, chronic 
arthritis, inflammatory bowel disease, 
lymphoma, leukemia, hyperglycemia, 
renal and pulmonary conditions, 
multiple sclerosis, and headaches.
Since BLA permits an investigator 
to isolate a single cell expressing the 
Figure 2. Monitoring the expression of β-lactamase in 
living cells. After loading the cells with an esterified (ace-
toxymethylated; AM) form of this substrate CCF2/4 (CCF2/4-
AM), cells from which the enzyme TEM-1 β-lactamase (BLA) 
is absent are green (A), whereas the BLA-expressing cells are 
seen as blue (B).
A
B
94 ı BioTechniques ı www.biotechniques.com Vol. 42 ı No. 1 ı 2007
Mini-Review
enzyme from a population, it should 
be the system of choice for monitoring 
rare events, such as homologous 
recombination in somatic cells that 
occurs at a very low frequency. That 
the BLA reporter system is versatile 
enough to be used for this purpose is 
demonstrated by the fact that a robust 
and sensitive GR cell-based assay 
was developed using a novel one-arm 
homologous recombination-based 
approach in HEK 293T cells; the 
details of how this was carried out are 
described in Reference 13. Briefly, a 
3.6-kb region spanning the 3′ end of 
exon 5 to the middle of intron 6 of the 
GR gene was amplified by PCR. This 
fragment was then cloned immedi-
ately downstream of the GAL4-DNA 
binding domain (GAL4-DBD; amino 
acids 1–147), such that the 151 amino 
acid of the resulting fusion protein 
represents the 500th amino acid of 
GR, which in turn corresponds to 
the first amino acid of the GR ligand 
binding domain (LBD) that spans 
from amino acid 500–777 (31). The 
three amino acids at positions 148, 
149, and 150 arise from the plasmid 
polylinker codons. The plasmid was 
designed in such a way that, after 
transfection, a precise homologous 
recombination event would culminate 
in the production of the GAL4(DBD)-
GR(LBD) from the strong cytomega-
lovirus (CMV) promoter. After 
digestion with a restriction enzyme, 
the linearized plasmid was used to 
transfect 100 million HEK 293T 
cells, which had previously been 
stably transfected with a BLA reporter 
plasmid under the control of an 
upstream activating sequence (UAS) 
containing seven GAL4-DBD binding 
sites (plasmid referred to as pUASGal4-
BLA). The transfection efficiency was 
estimated to be 0.2%. To identify stably 
transfected cells in which the targeted 
plasmid had integrated accurately, the 
cells were starved for 24 h and then 
treated with 1 μM dexamethasone, 
a GR ligand, for 16 h. Subsequently, 
100 million cells were loaded with 
CCF2-AM from which 500,000 BLA-
positive cells were recovered by FACS. 
After eliminating cells constitutively 
expressing BLA from this pool, the 
cycle of starving cells, treating them 
with dexamethasone, loading them 
with CCF2-AM and FACS sorting was 
repeated twice. From the final FACS, 
about 300 intense blue single cells 
were collected in individual wells of 
a 96-well plate from which approxi-
mately 200 survived. To obtain cell 
lines highly responsive to dexameth-
asone, each of the expanded 200 
transgenic clonal cell lines was charac-
terized further. This exercise led to the 
identification of several cell lines that 
were validated by reverse transcription 
PCR (RT-PCR) to ascertain that the 
targeting vector had integrated at the 
appropriate locus (this analysis made 
use of two primers—one designed to 
anneal within the GAL4-DBD region 
and the other to an endogenous GR 
exon not cloned in the construct). 
Western blot analysis on extract 
prepared from one of the cell lines with 
α-GAL4-DBD antibody revealed the 
presence of a 427 amino acid chimeric 
GAL4(DBD)-GR(LBD) protein with a 
molecular weight of 46 kDa.
This GR cell-based assay engineered 
by homologous recombination exhibits 
an excellent dynamic range; treating 
the engineered HEK 293T cells first 
with 1 μM dexamethasone for 16 h 
and then loading with CCF4-AM for 
1 h results in a >13-fold induction of 
BLA expression. Moreover, the high 
Z′ factor value (0.83) demonstrates the 
robustness of the GR assay. Since the 
assay is fully miniaturizable and has 
been found to perform equally well 
in 384- to 3456-well plates, it should 
serve as a useful tool for drug hunters.
Development of the GR assay using 
homologous recombination demon-
strates that such assays can indeed be 
developed using the BLA technology. 
Additionally, this powerful approach, 
which allows an investigator to insert 
a DNA sequence anywhere in the 
genome, is equally useful for intro-
ducing an affinity tag, overexpressing 
a gene, or producing a transgenic 
knockout cell line.
CONCLUSION
The BLA reporter system outshines 
other reporter gene technologies in 
terms of its sensitivity, robustness, 
ease-of-use, and because it can be used 
for studying gene expression in living 
cells. It is for these reasons that this 
technology serves as an excellent tool, 
not only academic laboratories engaged 
in basic research, but also for research 
scientists in industry who are in the 
business of developing cost-effective 
and miniaturizable cell-based assays. 
From the competing reporter gene 
technologies, no other system offers a 
FACS-compatible, ratiometric, HTS-
ready technology.
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